Literature DB >> 6767791

A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis.

R C Moellering, B E Murray, S C Schoenbaum, J Adler, C B Wennersten.   

Abstract

A patient with enterococcal endocarditis, who relapsed after repeated courses of apparently adequate treatment with ampicillin plus gentamicin, was subsequently cured with ampicillin-tobramycin therapy. The organisms isolated from this patient were strains of Streptococcus faecalis that were resistant to penicillin (or ampicillin)-gentamicin synergism but not to penicillin (or ampicillin)-tobramycin synergism. The mechanism of resistance in these strains appears to be related to a specific defect in the intracellular uptake of gentamicin (but not tobramycin) in the presence of penicillin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767791     DOI: 10.1093/infdis/141.1.81

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Antimicrobial resistance among enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 2.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 3.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

4.  Relationship between the level of acquired resistance to gentamicin and synergism with amoxicillin in Enterococcus faecalis.

Authors:  Elisabeth Aslangul; Raymond Ruimy; Françoise Chau; Louis Garry; Antoine Andremont; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 5.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

6.  In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.

Authors:  C P Doit; S P Bonacorsi; A J Fremaux; G Sissia; R Cohen; P L Geslin; E H Bingen
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Antimicrobial therapy of streptococcal endocarditis.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol       Date:  1982-10       Impact factor: 3.267

8.  Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.

Authors:  M K Hayden; G I Koenig; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

9.  Penicillin-induced effects on streptomycin uptake and early bactericidal activity differ in viridans group and enterococcal streptococci.

Authors:  M H Miller; M A el-Sokkary; S A Feinstein; F D Lowy
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

10.  Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.

Authors:  P M Sullam; M G Täuber; C J Hackbarth; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.